vs

Side-by-side financial comparison of Natera, Inc. (NTRA) and BOSTON BEER CO INC (SAM). Click either name above to swap in a different company.

Natera, Inc. is the larger business by last-quarter revenue ($665.5M vs $385.7M, roughly 1.7× BOSTON BEER CO INC). Natera, Inc. runs the higher net margin — 7.1% vs -5.8%, a 12.9% gap on every dollar of revenue. On growth, Natera, Inc. posted the faster year-over-year revenue change (39.8% vs -4.1%). Natera, Inc. produced more free cash flow last quarter ($37.8M vs $22.1M). Over the past eight quarters, Natera, Inc.'s revenue compounded faster (34.5% CAGR vs -4.9%).

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendment...

The Boston Beer Company is an American brewery founded in 1984 by James "Jim" Koch and Rhonda Kallman. Boston Beer Company's first brand of beer was named Samuel Adams after Founding Father Samuel Adams, an American revolutionary patriot. Since its founding, Boston Beer has started several other brands, and in 2019 completed a merger with Dogfish Head Brewery.

NTRA vs SAM — Head-to-Head

Bigger by revenue
NTRA
NTRA
1.7× larger
NTRA
$665.5M
$385.7M
SAM
Growing faster (revenue YoY)
NTRA
NTRA
+43.9% gap
NTRA
39.8%
-4.1%
SAM
Higher net margin
NTRA
NTRA
12.9% more per $
NTRA
7.1%
-5.8%
SAM
More free cash flow
NTRA
NTRA
$15.7M more FCF
NTRA
$37.8M
$22.1M
SAM
Faster 2-yr revenue CAGR
NTRA
NTRA
Annualised
NTRA
34.5%
-4.9%
SAM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NTRA
NTRA
SAM
SAM
Revenue
$665.5M
$385.7M
Net Profit
$47.3M
$-22.5M
Gross Margin
43.5%
Operating Margin
-3.4%
-8.6%
Net Margin
7.1%
-5.8%
Revenue YoY
39.8%
-4.1%
Net Profit YoY
187.9%
41.9%
EPS (diluted)
$0.36
$-1.97

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NTRA
NTRA
SAM
SAM
Q4 25
$665.5M
$385.7M
Q3 25
$592.2M
$537.5M
Q2 25
$546.6M
$587.9M
Q1 25
$501.8M
$453.9M
Q4 24
$476.1M
$402.3M
Q3 24
$439.8M
$605.5M
Q2 24
$413.4M
$579.1M
Q1 24
$367.7M
$426.1M
Net Profit
NTRA
NTRA
SAM
SAM
Q4 25
$47.3M
$-22.5M
Q3 25
$-87.5M
$46.2M
Q2 25
$-100.9M
$60.4M
Q1 25
$-66.9M
$24.4M
Q4 24
$-53.8M
$-38.8M
Q3 24
$-31.6M
$33.5M
Q2 24
$-37.5M
$52.3M
Q1 24
$-67.6M
$12.6M
Gross Margin
NTRA
NTRA
SAM
SAM
Q4 25
43.5%
Q3 25
50.8%
Q2 25
49.8%
Q1 25
48.3%
Q4 24
39.9%
Q3 24
46.3%
Q2 24
46.0%
Q1 24
43.7%
Operating Margin
NTRA
NTRA
SAM
SAM
Q4 25
-3.4%
-8.6%
Q3 25
-16.5%
11.5%
Q2 25
-20.2%
14.0%
Q1 25
-15.8%
7.4%
Q4 24
-13.6%
-13.9%
Q3 24
-8.9%
7.6%
Q2 24
-10.6%
12.2%
Q1 24
-20.2%
3.6%
Net Margin
NTRA
NTRA
SAM
SAM
Q4 25
7.1%
-5.8%
Q3 25
-14.8%
8.6%
Q2 25
-18.5%
10.3%
Q1 25
-13.3%
5.4%
Q4 24
-11.3%
-9.6%
Q3 24
-7.2%
5.5%
Q2 24
-9.1%
9.0%
Q1 24
-18.4%
3.0%
EPS (diluted)
NTRA
NTRA
SAM
SAM
Q4 25
$0.36
$-1.97
Q3 25
$-0.64
$4.25
Q2 25
$-0.74
$5.45
Q1 25
$-0.50
$2.16
Q4 24
$-0.41
$-3.23
Q3 24
$-0.26
$2.86
Q2 24
$-0.30
$4.39
Q1 24
$-0.56
$1.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NTRA
NTRA
SAM
SAM
Cash + ST InvestmentsLiquidity on hand
$223.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.7B
$846.3M
Total Assets
$2.4B
$1.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NTRA
NTRA
SAM
SAM
Q4 25
$223.4M
Q3 25
$1.0M
$250.5M
Q2 25
$16.0M
$212.4M
Q1 25
$17.8M
$152.5M
Q4 24
$22.7M
$211.8M
Q3 24
$29.5M
$255.6M
Q2 24
$90.3M
$219.3M
Q1 24
$69.1M
$205.4M
Stockholders' Equity
NTRA
NTRA
SAM
SAM
Q4 25
$1.7B
$846.3M
Q3 25
$1.3B
$911.0M
Q2 25
$1.2B
$912.3M
Q1 25
$1.2B
$897.0M
Q4 24
$1.2B
$916.2M
Q3 24
$878.5M
$1.0B
Q2 24
$836.5M
$1.0B
Q1 24
$794.1M
$1.0B
Total Assets
NTRA
NTRA
SAM
SAM
Q4 25
$2.4B
$1.2B
Q3 25
$1.8B
$1.2B
Q2 25
$1.8B
$1.3B
Q1 25
$1.7B
$1.2B
Q4 24
$1.7B
$1.3B
Q3 24
$1.6B
$1.4B
Q2 24
$1.5B
$1.4B
Q1 24
$1.5B
$1.4B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NTRA
NTRA
SAM
SAM
Operating Cash FlowLast quarter
$73.9M
$39.9M
Free Cash FlowOCF − Capex
$37.8M
$22.1M
FCF MarginFCF / Revenue
5.7%
5.7%
Capex IntensityCapex / Revenue
5.4%
4.6%
Cash ConversionOCF / Net Profit
1.56×
TTM Free Cash FlowTrailing 4 quarters
$109.1M
$215.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NTRA
NTRA
SAM
SAM
Q4 25
$73.9M
$39.9M
Q3 25
$59.4M
$101.8M
Q2 25
$37.6M
$126.5M
Q1 25
$44.5M
$1.9M
Q4 24
$52.9M
$41.9M
Q3 24
$51.8M
$115.9M
Q2 24
$4.0M
$96.0M
Q1 24
$27.0M
$-4.9M
Free Cash Flow
NTRA
NTRA
SAM
SAM
Q4 25
$37.8M
$22.1M
Q3 25
$37.0M
$89.2M
Q2 25
$11.7M
$112.2M
Q1 25
$22.6M
$-8.0M
Q4 24
$34.8M
$18.4M
Q3 24
$35.5M
$99.2M
Q2 24
$-7.7M
$75.6M
Q1 24
$6.7M
$-20.6M
FCF Margin
NTRA
NTRA
SAM
SAM
Q4 25
5.7%
5.7%
Q3 25
6.2%
16.6%
Q2 25
2.1%
19.1%
Q1 25
4.5%
-1.8%
Q4 24
7.3%
4.6%
Q3 24
8.1%
16.4%
Q2 24
-1.9%
13.1%
Q1 24
1.8%
-4.8%
Capex Intensity
NTRA
NTRA
SAM
SAM
Q4 25
5.4%
4.6%
Q3 25
3.8%
2.3%
Q2 25
4.7%
2.4%
Q1 25
4.3%
2.2%
Q4 24
3.8%
5.8%
Q3 24
3.7%
2.8%
Q2 24
2.8%
3.5%
Q1 24
5.5%
3.7%
Cash Conversion
NTRA
NTRA
SAM
SAM
Q4 25
1.56×
Q3 25
2.21×
Q2 25
2.09×
Q1 25
0.08×
Q4 24
Q3 24
3.46×
Q2 24
1.83×
Q1 24
-0.39×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons